AbbVie Inc. (ABBV) — What Changed
AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses s…
BestStocks surfaces only meaningful changes—backed by price, volume, catalysts, and peer context—so you can focus on what matters.
1. What Changed Since Last Close
AbbVie (ABBV) filed an 8-K on 2026-06-22 with no accompanying price movement (0%).
ABBV rallied 4.20% to $253.35 and hit a new 52-week high on June 26, 2026. Intraday volume reached 52.5M shares, well ab
ABBV included in heatmap showing defensive healthcare sector gaining amid tech rotation.
AbbVie Inc. (ABBV) moved +3.51% from $234.89 to $243.14 on 2026-06-25, reaching a new 30-day high. We checked news, earn
ABBV rose 0.63% to $254.94 on intraday trading with below-average volume (0.47x expected at 150 minutes into session). A
2. Change Timeline
| Date | Change | Price Reaction | Volume | Confidence ↓ |
|---|---|---|---|---|
| Jun 22 | FNew Filing | +6.25% | 0.61x | Medium |
| Jun 26 | VPrice Move Up | +4.20% | 3.25x | Medium |
| undefined NaN | NNews | — | — | Medium |
| Jun 25 | VPrice Move Up | +3.51% | 0.63x | Medium |
| Jun 29 | VPrice Move Up | — | — | Low |
3. Why It Moved
- ABBV rallied 4.20% to $253.35 and hit a new 52-week high on June 26, 2
- AbbVie Inc. (ABBV) moved +3.51% from $234.89 to $243.14 on 2026-06-25,
4. Peer / Sector Confirmation
| Symbol | Today | 5D | Rel. Vol | |
|---|---|---|---|---|
| ABBV | -0.02% | — | 0.59x | Leader |
| LLY | +7.13% | — | — | |
| UNH | +2.97% | — | — | |
| JNJ | +3.99% | — | — | |
| PFE | +2.62% | — | — | |
| MRK | +2.56% | — | — |
5. SEC Filing Watch
6. Analyst Expectations
7. Bull vs Bear Thesis Shift
8. What To Watch Next
| Date | Event | Impact | |
|---|---|---|---|
| Jul 31 | Earnings Release | High | |
| Aug 7est. | 10-Q Filing | Medium |